Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activation-Reference-Cited by-同舟云学术

Epigenetic silencing of ASPP1 confers 5‐FU resistance in clear cell renal cell carcinoma by preventing p53 activation

Published:2017-07-10 Issue:7 Volume:141 Page:1422-1433
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wang Xingwen¹²,Cheng Yiwei³,Zhu YiFu¹,Li Huayi¹,Ge Wenjie¹²,Wu Xiaoliang¹,Zhao Kunming¹,Yuan Jinyang³,Li Zhenglin⁴,Jiang Shijian¹,Han Zhengbin¹,Jiang Qinghua¹,Wu Qiong¹,Liu Tao⁵,Zhang Cheng³,Yu Miao⁴,Hu Ying¹²^ORCID

Affiliation:

1. School of Life Science and TechnologyHarbin Institute of TechnologyHarbin Heilongjiang150001 China

2. Shenzhen Graduate School of Harbin Institute of TechnologyXili University CityNanshanShenzhen Guangdong518055 China

3. The First Affiliated HospitalHarbin Medical UniversityHarbin Heilongjiang150081 China

4. School of Chemical Engineering and TechnologyHarbin Institute of TechnologyHarbin Heilongjiang150001 China

5. Shenzhen Luohu People's Hospital, Shenzhen Zhongxun Precision Medicine Research InstituteShenzhen Guangdong518001 China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Heilongjiang Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30852

Reference45 articles.

1. SnapShot: Renal Cell Carcinoma

2. Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity

3. Drugs, surgery and survival in RCC

4. Renal cell carcinoma

5. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Buti S;Anticancer Drugs,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Methylation as Drug Sensitivity Marker in RCC: A Systematic Review;Epigenomes;2024-07-15

2. Interdependent Nuclear Co-Trafficking of ASPP1 and p53 Aggravates Cardiac Ischemia/Reperfusion Injury;Circulation Research;2023-01-20

3. Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma;WIREs Mechanisms of Disease;2022-07-21

4. CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma;Frontiers in Immunology;2022-02-22

5. MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis;Translational Andrology and Urology;2021-09